[Microbiota and metabolic syndrome]

Area of Science:

• Microbiology
• Metabolic Health
• Cardiovascular Science

Background:

• The gut microbiome's role in disease pathogenesis is increasingly recognized.
• Rising prevalence of diabetes, obesity, and cardiovascular diseases (CVD) despite medical advancements.
• Microbial dysbiosis, an imbalance in gut bacteria, is associated with metabolic syndrome and atherosclerosis.

Purpose of the Study:

• To explore the connection between gut bacteria and the development of metabolic and cardiovascular diseases.
• To investigate the mechanisms by which microbial dysbiosis contributes to these conditions.
• To evaluate the potential of dietary interventions for managing these diseases.

Main Methods:

• Review of current literature on gut microbiota, metabolic syndrome, and cardiovascular diseases.
• Analysis of the biochemical pathways affected by microbial dysbiosis, including metabolite production and bile acid alterations.
• Examination of the impact of carbohydrate and protein fermentation on host metabolic pathways.

Main Results:

• Microbial dysbiosis leads to increased harmful metabolites and altered bile acid profiles.
• These changes activate insulin resistance pathways, contributing to obesity, diabetes, and atherosclerosis.
• Gut bacteria composition directly influences the pathogenesis of metabolic and cardiovascular conditions.

Conclusions:

• Microbial dysbiosis is a significant factor in the development of obesity, diabetes, and cardiovascular diseases.
• Dietary strategies, including prebiotics and probiotics, offer a promising therapeutic avenue.
• Further research into microbiome-targeted interventions is warranted for metabolic and cardiovascular health.